- Home
- BIRK vs BRKR Comparison
BIRK vs BRKR Comparison
Compare BIRK & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BIRK | BRKR |
|---|---|---|
| Founded | 1774 | 1960 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.6B |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BIRK | BRKR |
|---|---|---|
| Price | $35.82 | $36.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $62.69 | $48.92 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $13.71 | $6.27 |
| Revenue Next Year | $14.21 | $3.78 |
| P/E Ratio | $17.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.06 | $28.53 |
| 52 Week High | $57.39 | $56.22 |
Technical Indicators
Market Signals| Indicator | BIRK | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 49.65 |
| Support Level | $33.06 | $35.88 |
| Resistance Level | $42.19 | $37.32 |
| Average True Range (ATR) | 1.54 | 1.66 |
| MACD | -0.01 | 0.47 |
| Stochastic Oscillator | 45.47 | 88.78 |
Price Performance
Historical ComparisonAbout BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.